Healthy Participants Study

1
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Prothena
ProthenaDUBLIN 2, Ireland
1 program
1
PRX019Phase 11 trial
Active Trials
NCT06699680Recruiting48Est. Jan 2026

Trial Timeline

Clinical trial activity over time

2024
2025
2026
ProthenaPRX019

Clinical Trials (1)

Total enrollment: 48 patients across 1 trials

Phase 1 Study of PRX019 in Healthy Adult Volunteers

Start: Nov 2024Est. completion: Jan 202648 patients
Phase 1Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 48 patients
1 companies competing in this space